Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic, and fatal interstitial lung disease (ILD) of unknown etiology that primarily affects the elderly. Patients with IPF suffer from a heavy symptom burden and usually have a poor quality of life. Dyspnea and dry cough are predomina...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Upsala Medical Society
2022-07-01
|
| Series: | Upsala Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://ujms.net/index.php/ujms/article/view/8739/14759 |
| _version_ | 1797705206200270848 |
|---|---|
| author | Svetlana Kašiković Lečić Jovan Javorac Dejan Živanović Aleksandra Lovrenski Dragana Tegeltija Jelena Zvekić Svorcan Jadranka Maksimović |
| author_facet | Svetlana Kašiković Lečić Jovan Javorac Dejan Živanović Aleksandra Lovrenski Dragana Tegeltija Jelena Zvekić Svorcan Jadranka Maksimović |
| author_sort | Svetlana Kašiković Lečić |
| collection | DOAJ |
| description | Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic, and fatal interstitial lung disease (ILD) of unknown etiology that primarily affects the elderly. Patients with IPF suffer from a heavy symptom burden and usually have a poor quality of life. Dyspnea and dry cough are predominant symptoms of IPF. Although pain is not considered one of the main symptoms of IPF, it can occur for a variety of reasons, such as hypoxia, coughing, muscle and nerve damage, deconditioning, and steroid use. The prevalence of pain in IPF patients varies greatly, ranging from around 30 to 80%, with the prevalence being estimated mostly among patients in the end-of-life period. It manifests itself in the form of muscle pain, joint discomfort, or back and chest pain. Approaches to the treatment of chronic musculoskeletal pain in patients with IPF include pharmacological and non-pharmacological measures that are also important to optimize the treatment of other symptoms (dyspnea and cough) and the optimal treatment of comorbidities. Given the scarcity of data on this symptom in the literature, this article summarizes what is currently known about the etiology and treatment of musculoskeletal pain in IPF. |
| first_indexed | 2024-03-12T05:32:43Z |
| format | Article |
| id | doaj.art-a93df68bc2564200aaf9ef4783c6179f |
| institution | Directory Open Access Journal |
| issn | 0300-9734 2000-1967 |
| language | English |
| last_indexed | 2024-03-12T05:32:43Z |
| publishDate | 2022-07-01 |
| publisher | Upsala Medical Society |
| record_format | Article |
| series | Upsala Journal of Medical Sciences |
| spelling | doaj.art-a93df68bc2564200aaf9ef4783c6179f2023-09-03T06:47:31ZengUpsala Medical SocietyUpsala Journal of Medical Sciences0300-97342000-19672022-07-011271910.48101/ujms.v127.87398739Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a reviewSvetlana Kašiković Lečić0Jovan Javorac1Dejan Živanović2Aleksandra Lovrenski3Dragana Tegeltija4Jelena Zvekić Svorcan5Jadranka Maksimović6Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, SerbiaInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, SerbiaCollege of Vocational Studies for the Education of Preschool Teachers and Sports Trainers, Department of Biomedical Sciences, Subotica, SerbiaInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, SerbiaInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, SerbiaSpecial Hospital for Rheumatic Diseases, Novi Sad, SerbiaInstitute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, SerbiaIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic, and fatal interstitial lung disease (ILD) of unknown etiology that primarily affects the elderly. Patients with IPF suffer from a heavy symptom burden and usually have a poor quality of life. Dyspnea and dry cough are predominant symptoms of IPF. Although pain is not considered one of the main symptoms of IPF, it can occur for a variety of reasons, such as hypoxia, coughing, muscle and nerve damage, deconditioning, and steroid use. The prevalence of pain in IPF patients varies greatly, ranging from around 30 to 80%, with the prevalence being estimated mostly among patients in the end-of-life period. It manifests itself in the form of muscle pain, joint discomfort, or back and chest pain. Approaches to the treatment of chronic musculoskeletal pain in patients with IPF include pharmacological and non-pharmacological measures that are also important to optimize the treatment of other symptoms (dyspnea and cough) and the optimal treatment of comorbidities. Given the scarcity of data on this symptom in the literature, this article summarizes what is currently known about the etiology and treatment of musculoskeletal pain in IPF.https://ujms.net/index.php/ujms/article/view/8739/14759ipfdyspneacoughpaintreatment |
| spellingShingle | Svetlana Kašiković Lečić Jovan Javorac Dejan Živanović Aleksandra Lovrenski Dragana Tegeltija Jelena Zvekić Svorcan Jadranka Maksimović Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review Upsala Journal of Medical Sciences ipf dyspnea cough pain treatment |
| title | Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review |
| title_full | Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review |
| title_fullStr | Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review |
| title_full_unstemmed | Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review |
| title_short | Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review |
| title_sort | management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis a review |
| topic | ipf dyspnea cough pain treatment |
| url | https://ujms.net/index.php/ujms/article/view/8739/14759 |
| work_keys_str_mv | AT svetlanakasikoviclecic managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT jovanjavorac managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT dejanzivanovic managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT aleksandralovrenski managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT draganategeltija managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT jelenazvekicsvorcan managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview AT jadrankamaksimovic managementofmusculoskeletalpaininpatientswithidiopathicpulmonaryfibrosisareview |